Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Duloxetine

Duloxetine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Duloxetine

104 trials tracked of Duloxetine: 88 in phase 3 or 4 and 3 with published results. The most-cited published study has 24 citations.

104Trials tracked
88Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 41 Phase 3 47 Phase 2 7 Phase 1 2 Other / NA 7
  1. Phase 3 A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder Completed · 24 cited
  2. Phase 4 The BEST Trial: Biomarkers for Evaluating Spine Treatments Completed · 7 cited
  3. Phase 4 Pain Response Evaluation of a Combined Intervention to Cope Effectively Completed · 2 cited
  4. Phase 4 Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression Completed
  5. Phase 4 Effect of Combined Morphine and Duloxetine on Chronic Pain Completed
  6. Phase 4 Comparing Effectiveness of Duloxetine and Desipramine in Patients With Chronic Pain: A Pragmatic Trial Using Point of Care Randomization Completed
Show 44 more trials
  1. Phase 4 The Back Pain Consortium Research Program Study Completed
  2. Phase 4 Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine Completed
  3. Phase 4 Switching to Duloxetine in Patients With Depression Completed
  4. Phase 4 Duloxetine for Menopausal Depression Completed
  5. Phase 4 A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression Completed
  6. Phase 4 Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression Completed
  7. Phase 4 A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms Completed
  8. Phase 4 A Study in Depression and Associated Painful Physical Symptoms Completed
  9. Phase 4 Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression Completed
  10. Phase 4 Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder Completed
  11. Phase 4 Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations Completed
  12. Phase 4 Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery Completed
  13. Phase 4 A Study of the Neurobiology of Depression Completed
  14. Phase 4 Duloxetine in Osteoarthritis (OA) Pain Completed
  15. Phase 4 A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients Completed
  16. Phase 4 A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia Completed
  17. Phase 4 A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients Completed
  18. Phase 4 A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression Completed
  19. Phase 4 Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults Completed
  20. Phase 4 Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) Completed
  21. Phase 4 Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease Completed
  22. Phase 4 Duloxetine for Chronic Depression: a Double-blind Study Completed
  23. Phase 4 A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache Completed
  24. Phase 4 Duloxetine Treatment in Elderly With Dysthymia Completed
  25. Phase 4 A Study for Adult Patients With Fibromyalgia Completed
  26. Phase 4 An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder Completed
  27. Phase 4 The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder Completed
  28. Phase 4 Antidepressant Medication Plus Donepezil for Treating Late-life Depression Completed
  29. Phase 4 A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP) Completed
  30. Phase 4 An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome Completed
  31. Phase 4 A Study of Patients With Major Depressive Disorder and Residual Apathy Completed
  32. Phase 4 A Study of Duloxetine in Elderly Generalized Anxiety Disorder Completed
  33. Phase 4 A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder Completed
  34. Phase 4 Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome Completed
  35. Phase 4 An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain Completed
  36. Phase 4 Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD) Completed
  37. Phase 3 A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression Completed
  38. Phase 3 A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder Completed
  39. Phase 3 A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression Completed
  40. Phase 3 A Study of Duloxetine (LY248686) in Participants With Chronic Osteoarthritis and Knee Pain in Japan Completed
  41. Phase 3 A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression Completed
  42. Phase 3 Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder Completed
  43. Phase 3 A Study in the Treatment of Children and Adolescents With Major Depressive Disorder Completed
  44. Phase 3 A Study to Test the Use of Duloxetine for Pain in MS Completed

Showing the 50 most-cited and recently-updated of 104 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.